https://scholars.lib.ntu.edu.tw/handle/123456789/637026
標題: | Clinical practice consensus for the diagnosis and management of melanoma in Taiwan | 作者: | Wu, Chiao-En YI-HUA LIAO Wu, Cheng-Lin RUOH-FANG YEN CHIA-CHI LIN Yang, Muh-Hwa Yen, Chueh-Chuan Su, Wu-Chou Yen, Chia-Jui Chang, Yi-Fang Wu, Ming-Fang Yang, Youngsen Lin, Chen-Yuan Yang, Wen-Chi Wang, Hui-Ching Li, Cheng-Yuan Ho, Yin-Yu Chang, Yao-Yu Wu, Chieh-Shan Hsu, Hsiu-Cheng Chen, Kuang-Hua Huang, Yenlin Chen, Chih-Jung Chuang, Pei-Ju Lai, Yung-Chi Huang, Yu-Yi Tseng, Neng-Chuan Huang, Yi-Ting CHIA-YU CHU Wen-Cheng Chang, John |
關鍵字: | Acral melanoma; Immunotherapy; Melanoma; Mucosal melanoma; Targeted therapy | 公開日期: | 2024 | 來源出版物: | Journal of the Formosan Medical Association = Taiwan yi zhi | 摘要: | Melanoma is rare in Taiwan. Asian melanoma is distinct from Western melanoma because acral and mucosal melanoma accounts for the majority of melanoma cases, leading to distinct tumor behaviors and genetic profiling. With consideration of the clinical guidelines in Western countries, Taiwanese experts developed a local clinical practice consensus guideline. This consensus includes diagnosis, staging, and surgical and systemic treatment, based only on clinical evidence, local epidemiology, and available resources evaluated by experts in Taiwan. This consensus emphasizes the importance of surgical management, particularly for sentinel lymph node biopsies. In addition, molecular testing for BRAF is mandatory for patients before systemic treatment. Furthermore, immunotherapy and targeted therapy are prioritized for systemic treatment. This consensus aimed to assist clinicians in Taiwan in diagnosing and treating patients according to available evidence. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/637026 | ISSN: | 0929-6646 | DOI: | 10.1016/j.jfma.2023.07.016 |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。